Wockhardt hit an upper circuit limit of 5% at Rs 470.30 at 9:24 IST on BSE on bargain hunting after the stock fell 23.99% in the preceding nine trading sessions to Rs 447.95 on 4 October 2013, from a recent low of Rs 589.30 on 20 September 2013.
Meanwhile, the BSE Sensex was down 97.18 points, or 0.49%, to 19,818.77.
On BSE, 2.35 lakh shares were traded in the counter compared with average volume of 2.84 lakh shares in the past one quarter.
The stock hit a high of Rs 470.30 and a low of Rs 427.05 so far during the day. The stock hit a record high of Rs 2,166.05 on 12 March 2013. The stock hit a 52-week low of Rs 344.15 on 8 August 2013.
The stock had underperformed the market over the past one month till 4 October 2013, rising 1.50% compared with the Sensex's 7.26% rise. The scrip had, however, underperformed the market in past one quarter, falling 54.90% as against Sensex's 2.60% rise.
The mid-cap company has an equity capital of Rs 54.88 crore. Face value per share is Rs 5.
On a consolidated basis, Wockhardt's net profit fell 14.5% to Rs 323.31 crore on 1.3% growth in net sales to Rs 1358.37 crore in Q1 June 2013 over Q1 June 2012.
Wockhardt is a high-technology intensive global pharmaceutical and biotechnology company with multi-disciplinary and innovative R&D programmes. It has three research centres globally and manufacturing facilities across India, USA, UK and Ireland. The company has a significant presence in USA, Europe and India.
Powered by Capital Market - Live News
